FDA and Australian Therapeutic Goods Administration Exchange Letters on Orphan Drug Status

Summary

The FDA is notifying the public of an exchange of letters with the Australian Therapeutic Goods Administration regarding orphan drug status, a process to facilitate the exchange of documents and information related to a potential orphan drug.